Rani Therapeutics Holdings, Inc. RANI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.14M | -29.44M | -29.67M | -28.32M | -29.69M |
| Total Depreciation and Amortization | 722.00K | 810.00K | 900.00K | 980.00K | 1.02M |
| Total Amortization of Deferred Charges | 91.00K | 149.00K | 207.00K | 232.00K | 232.00K |
| Total Other Non-Cash Items | 7.67M | 5.45M | 2.89M | -412.00K | -2.03M |
| Change in Net Operating Assets | 1.36M | 5.97M | 6.96M | -148.00K | -544.00K |
| Cash from Operations | -20.29M | -17.06M | -18.71M | -27.66M | -31.01M |
| Capital Expenditure | -47.00K | -52.00K | -88.00K | -119.00K | -244.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.93M | -27.66M | -6.94M | 26.58M | 27.18M |
| Cash from Investing | -47.98M | -27.71M | -7.03M | 26.46M | 26.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.22M | -16.97M | -20.72M | -15.00M | -12.50M |
| Issuance of Common Stock | 80.57M | 65.70M | 65.74M | 16.92M | 24.07M |
| Repurchase of Common Stock | -69.00K | -68.00K | -59.00K | -47.00K | -54.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.66M | -4.66M | -4.66M | -810.00K | -1.74M |
| Cash from Financing | 62.62M | 44.00M | 40.30M | 1.07M | 9.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.65M | -767.00K | 14.56M | -133.00K | 5.70M |